Skip to main content
OpenTrials
Completed

NCT Number: NCT00406042

The Role of Steroids Following Selective Laser Trabeculoplasty

To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

West Virginia University Eye Institute

Morgantown, West Virginia, 26505, United States

About this study

Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1% in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • glaucoma or ocular hypertension
  • need for bilateral SLT

Exclusion criteria

  • eye disease precluding accurate IOP measurement
  • contraindication to topical prednisolone acetate

Treatment and study plan

Prednisolone acetate 1%

Drug

Primary outcomes

  1. Intraocular pressure reduction

Secondary outcomes

  1. Anterior chamber inflammation

Sponsors and collaborators

Lead sponsor

West Virginia University

Other

Registry information

Official study title

The Role of Topical Prednisolone Acetate Following Selective Laser Trabeculoplasty

Important dates

Study start
2005
Study completion
2006
First posted
Dec 4, 2006
Registry last updated
Mar 29, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.